Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 20, 2017
Pharmacy Choice - News - Drug Delivery Systems - August 20, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 70     Next >>     Go To Page:

8/20/17 - New pharmacy designed to help treat people in their homes
Sometimes the healing process takes a while, but a new Grand Island- based business is designed to help patients heal in the comfort of their homes. Greater Nebraska Home Infusion, 2604 St. Patrick Ave., is owned by Rick and Cindy Lobeda. Lobeda has owned Midwest LTC Pharmacy, 3003 Frontage Road, for 10 years.
8/19/17 - Inj. Insulin Aspart 50 Percentage Plus Insulin Protamin 50 Percentage In 3 Ml Catridge With Free Pen And Needle For Use Of The Drug.: Brand Name: Novomix 50 Penfill. [TendersInfo (India)]
Quantity: 850.00 Numbers Bidding System: Single Bid System Inspection Agency: Others Payment Terms: As Per Annexure Attached At Special Conditions Of Contract For Medicines. As Per Drug Procurement Policy-2014, It Is Mentioned That Except Imported Drugs, If The Registered Firms Is/Are Marketing Drugs Manufactured By Other Manufacturing Units, Then.
8/19/17 - Q: My son has started teething
Q: My son has started teething, and I'd like to ease his discomfort. However, tests recently performed by the Food and Drug Administration on tablets by Hyland, a well-known maker of homeopathic products, revealed inconsistent amounts of belladonna, sometimes more than was listed on the label. The FDA asked Hyland to voluntarily recall its teething
8/18/17 - Bolus Injectors Market: Upcoming Demands and Growth Analysis 2023
Transparency Market Research Report Added "Bolus Injectors Market" to its database.Albany, NY 08/17/2017 Bolus injectors also referred as patch pumps are class of medical devices for subcutaneous self administration of biologics. Bolus injectors deliver a standardized volume of drug into subcutaneous tissue over a specified period of time.
8/18/17 - Data on Drug Delivery Systems Detailed by Researchers at University of Auckland (Preparation and evaluation of PLGA nanoparticle-loaded biodegradable...
Data on Drug Delivery Systems Detailed by Researchers at University of Auckland. Funders for this research include University of Auckland, Health Research Council of New Zealand. The news reporters obtained a quote from the research from the University of Auckland, "Peptide compatibility with PLGA and polyvinyl alcohol was confirmed via IR spectros
8/18/17 - EXELIXIS SUBMITS U.S. SUPPLEMENTAL NEW DRUG APPLICATION FOR CABOMETYX FOR THE TREATMENT OF PREVIOUSLY UNTREATED ADVANCED KIDNEY CANCER
Release date- 17082017- SOUTH SAN FRANCISCO, Calif.- Exelixis, Inc. today announced it has completed the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration for CABOMETYX tablets as a treatment for patients with previously untreated advanced renal cell carcinoma. The sNDA submission is based on results from th
8/18/17 - Findings from Manipal University Provides New Data about Drug Delivery Systems (Therapeutic Role and Drug Delivery Potential of Neuroinflammation as...
Findings from Manipal University Provides New Data about Drug Delivery Systems. Financial support for this research came from Department of Science and Technology, Government of Rajasthan. The news correspondents report that additional information may be obtained from A. Singh, Dept. of Biosciences, Manipal University Jaipur, Dehmi Kalan, Near JVK
8/18/17 - Findings from Shenyang Pharmaceutical University in Chemometrics Reported (Total detection of Tianma Toutong tablets for quality consistency by a...
Findings from Shenyang Pharmaceutical University in Chemometrics Reported. According to news reporting originating from Shenyang, People's Republic of China, by NewsRx correspondents, research stated, "A fingerprint method was developed and combined with chemometrics for quality evaluation of Tianma Toutong tablets, which are herbal medicine tablet
8/18/17 - Findings from University of Queensland Provides New Data about Drug Delivery Systems (Interfacial engineering for silica nanocapsules)
By a News Reporter-Staff News Editor at Drug Week Investigators publish new report on Drugs and Therapies- Drug Delivery Systems. According to news reporting originating in St. Lucia, Australia, by NewsRx journalists, research stated, "Silica nanocapsules have attracted significant interest due to their core- shell hierarchical structure.
8/18/17 - Findings in Drug Delivery Systems Reported from National Polytechnic Institute (Nanodevices that acts as nanocarriers for controlled and directed...
Findings in Drug Delivery Systems Reported from National Polytechnic Institute. The news correspondents obtained a quote from the research from National Polytechnic Institute, "Other applications of nanotechnology hold promise for the long run, such as using nanodevices for drug delivery or correcting the misfolding of proteins. Our news journalist
8/18/17 - Findings in the Area of Drug Delivery Systems Reported from Zhejiang University (Optimizing Multistep Delivery of PEGylated...
Findings in the Area of Drug Delivery Systems Reported from Zhejiang University. According to news reporting out of Hangzhou, People's Republic of China, by NewsRx editors, research stated, "Although TRAIL has been considered a promising broad-spectrum antitumor agent, its further application was limited by poor drug delivery and TRAIL-resistant tu
8/18/17 - Findings on Ampicillins Discussed by Investigators at St. Johns Hospital (Outcomes of an extended-infusion piperacillin-tazobactam protocol...
Findings on Ampicillins Discussed by Investigators at St. Johns Hospital. Our news journalists obtained a quote from the research from St. Johns Hospital, " John's Hospital's intensive and cardiac care units following IRB-approval. Data was collected for patients that received piperacillin-tazobactam in the ICU/CCU from December 19th, 2010 through
8/18/17 - LYNPARZA Gets Additional And Broad Approval In U.S. For Ovarian Cancer
LONDON- AstraZeneca and Merck& Co., Inc., announced that the US Food and Drug Administration has granted approval for the PARP inhibitor, LYNPARZA or olaparib, as follows:. New use of LYNPARZA tablets as a maintenance treatment of adult patients with recurrent, epithelial ovarian, fallopian tube or primary peritoneal cancer who are in a complete or
8/18/17 - New Drug Delivery Systems Findings Has Been Reported by Investigators at Liaocheng University [Glycosylated Platinum(IV) Complexes as Substrates for...
New Drug Delivery Systems Findings Has Been Reported by Investigators at Liaocheng University. Our news journalists obtained a quote from the research from Liaocheng University, "Glycosylated platinum complexes 5, 6, 7, and 8 had better antitumor activity of nearly 166- fold higher than the positive controls cisplatin, oxaliplatin, and satraplatin.
8/18/17 - New Findings from Chung Ang University in Drug Delivery Systems Provides New Insights (Enhancing Lysozyme Loading in Powderized Liposomes by...
New Findings from Chung Ang University in Drug Delivery Systems Provides New Insights. For more information on this research see: Enhancing Lysozyme Loading in Powderized Liposomes by Controlling Encapsulation Processes. Bulletin of the Korean Chemical Society, 2017; 38: 744-750. Bulletin of the Korean Chemical Society can be contacted at: Wiley-V
8/18/17 - New Findings from State Key Laboratory of Materials-Oriented Chemical Engineering in Drug Delivery Systems Provides New Insights (Porphyrin-Based...
For more information on this research see: Porphyrin-Based Covalent Triazine Frameworks: Porosity, Adsorption Performance, and Drug Delivery. Journal of Polymer Science Part A-Polymer Chemistry, 2017; 55: 2594-2600. Journal of Polymer Science Part A-Polymer Chemistry can be contacted at: Wiley, 111 River St, Hoboken 07030-5774, NJ, USA..
8/18/17 - Patent Issued for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients by an Inhibitor of Complement (USPTO 9718880)
By a News Reporter-Staff News Editor at Drug Week Alexion Pharmaceuticals, Inc. has been issued patent number 9718880, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Bell, Leonard; Rother, Russell P.; Evans, Mark J.. This patent was filed on May 6, 2016 and was published online o
8/18/17 - Pfizer Receives U.S. FDA Approval F=for Besponsa (Inotuzumab Ozogamicin)
Pfizer, a pharmaceutical company, issued the following news release:. Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved BESPONSA for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. 1 BESPONSA was reviewed and approved under the FDA's Breakthrough Therapy designatio
8/18/17 - PFIZER RECEIVES U.S. FDA APPROVAL FOR BESPONSA
Release date- 17082017- Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved BESPONSA for the treatment of adults with relapsed or refractory B cell precursor acute lymphoblastic leukemia. 1 BESPONSA was reviewed and approved under the FDA's Breakthrough Therapy designation and Priority Review programs.
8/18/17 - Researchers at Delaware Biotechnology Institute Target Drug Delivery Systems (Thermoresponsive Elastin-b-Collagen-Like Peptide Bioconjugate...
According to news reporting originating in Newark, Delaware, by NewsRx journalists, research stated, "Over the past few decades, peptide block copolymers have been widely employed in generating well-defined nanostructures as vehicles for targeted drug delivery applications. Financial supporters for this research include National Center for Research
8/18/17 - Researchers at Khon Kaen University Have Reported New Data on Drug Delivery Systems (Chitosan-clay nanocomposite microparticles for controlled drug...
By a News Reporter-Staff News Editor at Drug Week Investigators publish new report on Drugs and Therapies- Drug Delivery Systems. According to news originating from Khon Kaen, Thailand, by NewsRx correspondents, research stated, "Chitosan and clays can form nanocomposites via electrostatic interactions, offering an interesting potential as advanc
8/18/17 - Researchers Submit Patent Application, "Compositions and Methods for Modulating Cardiac Conditions", for Approval (USPTO 20170209555)
By a News Reporter-Staff News Editor at Drug Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors Dinarello, Charles A.; Abbate, Antonio; Lewis, Eli C., filed on December 16, 2016, was made available online on August 3, 2017. No assignee for this patent application has been made. News editors obtained t
8/18/17 - Vectura Group plc - Hikma Interim Results statement on its ANDA for generic Advair Diskus
Release date- 17082017- Chippenham, UK- Vectura Group plc, an industry-leading device and formulation business for inhaled airways products, today confirms the statement made by its partner Hikma Pharmaceuticals PLC in its interim results statement in respect of its abbreviated new drug application filing for a US generic version of Advair Diskus:'
8/18/17 - ViaDerma, Inc. Set to Begin Sales of its FDA Registered Topical Antibiotic in September with Initial Orders from Japan
ViaDerma, Inc., a specialty pharmaceutical company devoted to bringing new products to market, announced today that it has appointed Galaxy Solutions, Inc. as its sales representative for its first aid topical antibiotic which will be sold under the brand name Vitastem in select markets of Asia Pacific, starting in Japan. With competitive pricing f
8/18/17 - Windtree Therapeutics, Inc. (NASDAQ:WINT) Files An 8-K Entry into a Material Definitive Agreement
Windtree Therapeutics, Inc. (NASDAQ:WINT) Files An 8-K Entry into a Material Definitive AgreementItem 1.01 Entry into a Material Definitive Agreement. Effective August 14, 2017 (the Effective Date), Windtree Therapeutics, Inc. (the Company) entered into a Loan Agreement (Loan Agreement) with Lee's Pharmaceutical (HK) Ltd., a com
Articles(s): 1 - 25 of 70     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415